African Horse Sickness (Reportable)

African Horse Sickness is a highly fatal, non-contagious viral disease caused by an orbivirus transmitted by Culicoides biting midges. This devastating illness affects horses, mules, donkeys, and zebras, with horses being the most susceptible species and experiencing mortality rates that can exceed ninety percent in naive populations. The disease is endemic to sub-Saharan Africa but has historically caused outbreaks in North Africa, the Middle East, Spain, and Portugal, making it a significant international concern for the global equine industry.

The prevalence of African Horse Sickness is primarily concentrated in tropical and subtropical regions of Africa where the Culicoides midge vectors thrive year-round. However, climate change and international horse movement have raised concerns about potential spread to previously unaffected regions including Europe, Asia, and the Americas. All breeds and types of horses are susceptible, though the disease impacts are particularly devastating in areas where horses have no prior exposure or immunity to the virus.

The impact of African Horse Sickness on equine health is catastrophic, affecting multiple organ systems including the respiratory and cardiovascular systems. Infected horses may develop one of four clinical forms: the pulmonary form, cardiac form, mixed form, or horse sickness fever. The pulmonary and mixed forms carry the highest mortality rates, often causing death within days of symptom onset. Performance horses face immediate career-ending consequences, and the economic impact on breeding operations and equine industries in affected regions is substantial.

There is no specific treatment for African Horse Sickness, making prevention through vaccination and vector control absolutely critical. Early detection is essential for implementing quarantine measures and preventing disease spread to naive horse populations. Because this is a reportable disease in most countries, any suspected case must be immediately reported to veterinary authorities to enable rapid response and containment efforts.

African Horse Sickness is caused by the African horse sickness virus, an orbivirus belonging to the Reoviridae family. Nine distinct serotypes of the virus have been identified, numbered one through nine, with limited cross-protection between serotypes meaning horses can be infected multiple times by different viral strains. The virus is transmitted exclusively through the bites of infected Culicoides midges, particularly Culicoides imicola and related species, which serve as biological vectors for the pathogen.

There is no genetic or breed predisposition to African Horse Sickness infection, as all equids are equally susceptible to the virus upon exposure. However, species differences in susceptibility are notable: horses experience the highest mortality rates of ninety percent or greater, mules show intermediate susceptibility with mortality around fifty percent, and donkeys typically develop milder disease with mortality rates below ten percent. Zebras often act as reservoir hosts, maintaining the virus in endemic areas with minimal clinical signs.

Environmental and management factors play crucial roles in disease transmission and outbreak occurrence. The Culicoides midge vectors require specific environmental conditions including warm temperatures, high humidity, and standing water for breeding. Outbreaks typically occur during late summer and autumn when midge populations peak, and cease during winter months when vector activity decreases. Geographic location significantly influences risk, with areas having suitable midge habitats facing the greatest threat.

Risk factors for African Horse Sickness include housing horses in areas endemic for the disease, inadequate vector control measures, lack of vaccination in endemic regions, and international transport of horses from affected areas. Horses kept outdoors during peak midge activity hours of dusk and dawn face higher exposure risk. Climate conditions that extend the midge breeding season or expand vector geographic range increase outbreak probability in previously unaffected regions.

The pathophysiology of African Horse Sickness involves viral replication in lymph nodes following midge bite transmission, with subsequent viremia and spread to target organs. The virus damages endothelial cells lining blood vessels, causing increased vascular permeability, fluid accumulation in tissues, and hemorrhage. In the pulmonary form, massive fluid accumulation in the lungs leads to acute respiratory failure. The cardiac form results in fluid accumulation around the heart and subcutaneous edema. This endothelial damage and subsequent organ failure underlies the high mortality rate of this devastating disease.

Early warning signs of African Horse Sickness can be subtle and easily missed, particularly in the initial stages of infection. Horses may display mild fever, slight lethargy, and decreased appetite during the incubation period of five to fourteen days following midge bite exposure. Because horses naturally hide illness as prey animals, owners and handlers must remain vigilant for any behavioral changes or subtle deviations from normal activity levels during outbreak periods or in endemic regions.

Common symptoms vary depending on which of the four clinical forms develops. Horse sickness fever, the mildest form, causes transient fever, mild depression, and loss of appetite lasting one to two weeks followed by complete recovery. The cardiac form produces fever, swelling of the supraorbital fossae above the eyes creating a characteristic appearance, edema extending down the head and neck, and potential colic signs. The pulmonary form causes severe respiratory distress with labored breathing, coughing, and frothy nasal discharge.

Behavioral changes in affected horses include profound depression, complete loss of appetite, reluctance to move, and standing with head lowered and legs spread to ease breathing difficulty. Horses with the cardiac form may show anxiety and discomfort related to fluid accumulation. Those with pulmonary involvement often display open-mouth breathing, flared nostrils, and extended head and neck positions as they struggle to breathe. Some horses become recumbent and unable to rise as the disease progresses.

Physical signs depend on the clinical form but commonly include high fever reaching forty to forty-one degrees Celsius, increased heart and respiratory rates, visible sweating, and conjunctival injection with reddened eye membranes. The cardiac form produces distinctive swelling above the eyes, along the head, and extending to the neck and chest. Edema may be so severe that the horse's head appears swollen and disfigured. Cyanosis or bluish discoloration of mucous membranes indicates poor oxygenation.

Symptom progression in African Horse Sickness can be alarmingly rapid, particularly in the pulmonary and mixed forms. The pulmonary form may progress from initial fever to death within hours, with horses drowning in their own pulmonary fluid. The cardiac form typically develops over one to two weeks, with progressive edema and eventual heart failure. The mixed form combines respiratory and cardiac signs and carries mortality rates approaching one hundred percent.

Emergency symptoms requiring immediate veterinary intervention include severe respiratory distress with open-mouth breathing and frothy nasal discharge, profound weakness or inability to stand, extensive subcutaneous edema, and signs of cardiovascular collapse including rapid weak pulse and cold extremities. Any horse in an endemic area or with potential exposure history showing fever and respiratory or cardiovascular signs should be treated as a suspected case requiring immediate isolation and veterinary notification.

Physical examination of horses suspected of having African Horse Sickness reveals findings consistent with the clinical form present. Veterinarians assess vital signs including elevated temperature often exceeding forty degrees Celsius, increased respiratory rate and effort, and elevated heart rate with potential arrhythmias. Examination of the head may reveal characteristic supraorbital swelling in cardiac cases, while auscultation of the lungs may detect fluid accumulation and abnormal breathing sounds in pulmonary cases. Mucous membrane color and capillary refill time help assess cardiovascular status.

Diagnostic tests for African Horse Sickness include blood sample collection for virus isolation, polymerase chain reaction testing, and serological examination. PCR testing provides rapid identification of viral genetic material and can detect infection before antibodies develop. Serology testing using enzyme-linked immunosorbent assay or complement fixation tests identifies antibodies against the virus, though this may indicate past exposure rather than current infection. Complete blood count and serum chemistry panels assess overall health status and organ function.

Advanced diagnostics may include virus isolation from blood samples taken during the febrile viremic phase, which allows identification of the specific serotype involved. This information is crucial for epidemiological investigation and vaccine selection. Post-mortem examination of horses that succumb provides definitive diagnosis through identification of characteristic lesions including pulmonary edema, hydropericardium, and hemorrhages in multiple organs. Histopathology confirms viral damage to endothelial tissues.

Differential diagnosis for African Horse Sickness includes other causes of respiratory distress such as pneumonia, pleuropneumonia, and acute respiratory infections. The cardiac form may resemble other causes of edema including purpura hemorrhagica, equine infectious anemia, and heart disease. Equine viral arteritis produces similar signs and must be distinguished through laboratory testing. In non-endemic areas, any suspected case requires immediate notification of veterinary authorities for official investigation and laboratory confirmation.

Emergency and immediate treatment for African Horse Sickness is limited to supportive care, as no specific antiviral therapy exists for this disease. Affected horses should be immediately isolated to prevent potential mechanical transmission and to protect other horses from midge vectors that might feed on infected animals. Rest is essential, and affected horses should be maintained in cool, well-ventilated areas protected from midges. Stress must be minimized as it can accelerate disease progression.

Medical management focuses on symptomatic and supportive care to maintain organ function and comfort while the horse's immune system fights the infection. Anti-inflammatory medications including non-steroidal anti-inflammatory drugs may help reduce fever and inflammation. Corticosteroids have been used in some cases to reduce pulmonary inflammation, though their benefit remains debated. Cardiovascular support may include diuretics to reduce fluid accumulation in cardiac cases, though response is often poor.

There are no surgical interventions applicable to African Horse Sickness. The disease affects multiple organ systems through vascular damage that cannot be corrected surgically. In severe cases with respiratory compromise, emergency tracheostomy might provide temporary airway support, but this does not address the underlying pulmonary fluid accumulation and is rarely beneficial.

Supportive care includes intravenous fluid therapy to maintain hydration and support cardiovascular function, though fluid administration must be carefully monitored to avoid worsening pulmonary or peripheral edema. Nutritional support through easily digestible feeds helps maintain strength in horses that continue eating. Keeping horses cool through shade, fans, and cool water helps reduce metabolic stress during fever periods. Pain management ensures comfort during the illness course.

Rehabilitation and return to work is only relevant for horses that survive, primarily those with the milder horse sickness fever form. Recovery requires extended rest periods of several weeks to months to allow complete resolution of any cardiac or pulmonary damage. Horses should be gradually returned to exercise with careful monitoring for any signs of exercise intolerance or cardiac compromise. Survivors may have permanent damage requiring modified use expectations.

Treatment decisions must consider the extremely high mortality rate of African Horse Sickness, particularly the pulmonary and mixed forms. Euthanasia may be the most humane option for horses with severe respiratory distress or extensive edema who are suffering and have poor prognosis. Owners must be counseled about the likely fatal outcome and prepared for difficult decisions. The reportable nature of the disease means official veterinary involvement is mandatory.

Recovery timeline for African Horse Sickness varies dramatically depending on the clinical form and severity of disease. Horses with horse sickness fever typically recover within one to two weeks with minimal lasting effects. Those surviving the cardiac form may require four to eight weeks for resolution of edema and cardiovascular stabilization. The pulmonary and mixed forms rarely allow survival, but the few horses that recover may need months of convalescence. Complete recovery of cardiac function may take six months or longer.

Post-treatment care and monitoring for survivors requires careful attention to cardiovascular and respiratory function. Horses should remain at rest with limited exercise until veterinary clearance is obtained. Regular monitoring of heart rate, respiratory rate, and exercise tolerance helps identify any lasting damage. Electrocardiography may be useful to assess cardiac function in survivors of cardiac or mixed forms. Continued protection from midge exposure prevents reinfection with different serotypes.

Prognosis factors for African Horse Sickness are heavily influenced by the clinical form, with horse sickness fever carrying good prognosis while pulmonary and mixed forms are almost universally fatal. Early supportive intervention may improve outcomes for cardiac cases, though mortality remains high. Host species affects prognosis, with donkeys having much better survival rates than horses. Previous exposure or vaccination against related serotypes may provide partial protection and improve outcomes.

Long-term soundness outlook for survivors depends on the extent of organ damage sustained during acute illness. Horses recovering from horse sickness fever typically return to full function without lasting effects. Survivors of cardiac disease may have permanent heart damage limiting athletic performance or making them unsuitable for strenuous work. Pulmonary survivors may have reduced respiratory capacity. All survivors develop immunity to the infecting serotype but remain susceptible to the eight other serotypes.

Management practices for preventing African Horse Sickness focus heavily on reducing exposure to Culicoides midge vectors. Stabling horses during peak midge activity periods of dusk, overnight, and dawn significantly reduces bite exposure. Facilities should be located away from midge breeding areas including marshes, ponds, and areas of standing water. Fine mesh screens on stable windows and doors exclude midges from indoor areas. Environmental management to eliminate standing water reduces local midge populations.

Nutritional prevention has no direct role in African Horse Sickness, though maintaining horses in good body condition and health supports immune function. Horses with strong immune systems may mount more effective responses if exposed. Ensuring adequate nutrition during outbreak periods helps horses maintain condition despite the stress of intensive management and housing changes required for vector avoidance.

Exercise and conditioning modifications focus on timing rather than intensity. Horses should be exercised during daylight hours when midge activity is lowest. Avoid turnout and outdoor activities during dawn and dusk periods when vectors are most active. In endemic areas or during outbreaks, limiting outdoor time as much as practical reduces exposure risk while maintaining horse fitness through indoor or sheltered exercise options.

Environmental factors play crucial roles in African Horse Sickness prevention. Vector control measures including insecticide application to premises and horses reduce midge numbers and biting. Pyrethroid-based repellents and insecticides are commonly used. Fans in stables create air movement that discourages midge activity. Eliminating or treating standing water sources reduces midge breeding success. Location selection for new equine facilities should avoid areas with high midge populations.

Vaccination is the cornerstone of prevention in endemic areas. Live attenuated polyvalent vaccines covering multiple serotypes are available and widely used in Africa. Vaccination protocols typically involve annual boosters administered before the vector season begins. Vaccines are not licensed in non-endemic countries to prevent accidental introduction of vaccine virus strains. Movement restrictions and quarantine protocols prevent introduction of infected horses into disease-free areas. Import testing requirements and quarantine periods protect horse populations in non-endemic countries.

Daily management adjustments for horses in areas at risk for African Horse Sickness center on vector avoidance and early detection. Horses should be stabled from late afternoon through morning during midge season, with turnout limited to midday hours when vectors are least active. Daily health monitoring including temperature checks helps identify febrile horses before clinical signs develop. Staff should be trained to recognize early symptoms and report concerns immediately.

Housing and turnout considerations emphasize midge exclusion and environmental control. Stables should feature fine mesh screening on all openings to prevent midge entry. Fans improve air circulation and discourage midge activity. Stable locations should avoid proximity to wetlands, irrigation areas, and other midge breeding habitats. Turnout areas should be well-drained and distant from water sources. Manure management reduces organic matter that might support midge breeding.

Exercise modifications in endemic areas or during outbreak periods focus on timing and location. Schedule all riding, training, and exercise activities during the middle of the day when Culicoides midges are least active. Avoid exercising horses near water features, wooded edges, or other areas with high midge concentrations. Consider using insect repellents and protective sheets during any necessary outdoor activity. Indoor arenas provide protected exercise options.

Monitoring and ongoing care requirements include twice-daily health assessments during high-risk periods. Temperature monitoring is particularly important as fever is often the first sign of infection. Maintain detailed records of each horse's normal vital signs to enable recognition of subtle changes. Report any fever, lethargy, or respiratory changes immediately to veterinarians. Implement immediate isolation protocols for any horse showing suspicious symptoms.

Quality of life and use considerations must balance disease risk against horse welfare needs for movement and socialization. Extended stabling periods may cause stress, so enrichment activities and social contact where possible help maintain mental health. Monitor for complications of restricted turnout including weight gain, behavioral changes, and musculoskeletal issues from reduced movement. In endemic areas, vaccination allows more normal management while providing protection against clinical disease.

All horse breeds are equally susceptible to African Horse Sickness infection, as the virus does not discriminate based on breed or type. The disease affects Thoroughbreds, Warmbloods, Arabians, Quarter Horses, draft breeds, ponies, and all other equine breeds with similar severity. However, individual horses may vary in their response to infection based on overall health status, immune function, and whether they have any partial immunity from previous exposure to related serotypes.

Use and discipline considerations primarily relate to geographic location and management practices rather than breed. Horses in endemic regions of Africa face ongoing risk regardless of their intended use. Sport horses, breeding stock, and recreational horses all require equal protection through vaccination and vector control. International competition horses traveling to or through endemic regions face particular risk and require careful planning including appropriate vaccination schedules where permitted and strict midge avoidance protocols.

Genetic testing has no role in African Horse Sickness prevention as susceptibility is not genetically determined within the horse species. Breeding recommendations focus on geographic considerations rather than genetics. Breeding operations in endemic areas must implement rigorous vector control and vaccination programs to protect valuable breeding stock. Pregnant mares should receive extra protection as the virus can cross the placenta causing abortion. Foals from vaccinated mares receive passive immunity through colostrum but require their own vaccinations once maternal antibodies wane.

Commonly co-occurring conditions with African Horse Sickness are limited as the disease is typically fatal before secondary complications develop. However, horses with the cardiac form may develop secondary bacterial pneumonia due to pulmonary compromise and recumbency. Laminitis can occur in surviving horses secondary to systemic inflammation and circulatory disturbances. Horses with prolonged illness may develop pressure sores and muscle wasting from extended recumbency.

Conditions with similar symptoms that must be differentiated from African Horse Sickness include equine viral arteritis, which causes similar fever, edema, and respiratory signs but is caused by a different virus and has different epidemiology. Equine infectious anemia can cause fever, edema, and cardiovascular signs. Purpura hemorrhagica following strangles or other streptococcal infections produces dramatic limb and head swelling. Acute bacterial pneumonia causes respiratory distress and fever. Anthrax can cause sudden death with edema and hemorrhage.

Potential complications of African Horse Sickness in surviving horses include permanent cardiac damage with reduced exercise tolerance, chronic respiratory compromise from pulmonary scarring, and general debilitation requiring extended rehabilitation. Secondary bacterial infections may complicate recovery. Horses recovering from severe edema may have temporary or permanent lymphatic damage. The immune response to infection may trigger subsequent laminitis in some cases. Stress-related conditions including gastric ulceration can develop during illness and recovery periods.